TITLE

Statin benefits outweigh the risk of developing diabetes

PUB. DATE
September 2012
SOURCE
Diabetes Digest;2012, Vol. 11 Issue 3, p170
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports the findings of a new research that revealed that advantages of statin therapy on cardiovascular health outweigh the associated risk of developing T2D.
ACCESSION #
84469153

 

Related Articles

  • ACA: Your ADVOCATE. Statins Increase Diabetes Risk by 46 Percent.  // ACA News (American Chiropractic Association);Aug2015, Vol. 11 Issue 6, p6 

    The article reports on a population-based study which shows that statin therapy increases the risk of type 2 diabetes associated with impaired insulin sensitivity and insulin secretion.

  • Statins for the primary prevention of cardiovascular disease. Ebrahim, Shah; Taylor, Fiona C.; Brindle, Peter // BMJ: British Medical Journal;2/8/2014, Vol. 348 Issue 7944, p32 

    The article focuses on statins, indicated for secondary prevention of cardiovascular disease. It cites a review of statins by the Cholesterol Treatment Trialists Collaboration for both primary and secondary prevention which reported a 20% relative risk reduction per 1 mmol/L reduction in LDL...

  • Update on the Controversies of Statin Therapy. Karpman, Harold L. // Internal Medicine Alert;11/15/2012, Vol. 34 Issue 21, p161 

    After careful evaluation of all the published studies regarding the possible adverse effects of statin therapy, Jukema et al have concluded that there is no proven increased risk of cognitive decline or cancer development. However, there is a possible small increased risk for the development of...

  • Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular Disease: Grand Rounds Discussion From the Beth Israel Deaconess Medical Center. Mittleman, Murray A.; Taylor, William C.; Smetana, Gerald; Burns, Risa B. // Annals of Internal Medicine;8/18/2015, Vol. 163 Issue 4, p280 

    In November 2013, the American College of Cardiology and the American Heart Association released a clinical practice guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease (ASCVD) risk in adults. The recommendation identifies 4 patient groups with strong...

  • Use of statins to reduce the risk of cardiovascular disease in adults. Ford, Helen // Nursing Standard;5/29/2013, Vol. 27 Issue 39, p48 

    The relationship between serum cholesterol and cardiovascular disease is well established. Primary and secondary prevention of cardiovascular events involves the use of statins to reduce cholesterol levels, as recommended by the National Institute for Health and Care Excellence. This article...

  • High-Sensitivity C-Reactive Protein and Statin Initiation. Trpkovic, Andreja; Stanimirovic, Julijana; Rizzo, Manfredi; Resanovic, Ivana; Soskic, Sanja; Jevremovic, Danimir; Isenovic, Esma R. // Angiology;Jun2015, Vol. 66 Issue 6, p503 

    The assessment of cardiovascular risk and treatment of cardiovascular diseases are major public health issues worldwide. Inflammation is now recognized as a key regulatory process that links multiple risk factors for atherosclerosis. The substantial number of patients having cardiovascular...

  • PTEN Upregulation May Explain the Development of Insulin Resistance and Type 2 Diabetes with High Dose Statins. Birnbaum, Yochai; Nanhwan, Manjyot; Ling, Shukuan; Perez-Polo, Jose; Ye, Yumei; Bajaj, Mandeep // Cardiovascular Drugs & Therapy;Oct2014, Vol. 28 Issue 5, p447 

    Purpose: Statins increase the incidence of new onset diabetes. Prolonged statin therapy upregulates PTEN expression. PTEN levels are also elevated in diabetic animals. Activation of protein kinase A by cAMP decreases PTEN expression. We assessed whether prolonged treatment with rosuvastatin...

  • Lab Reports. Hampton, Tracy // JAMA: Journal of the American Medical Association;8/6/2014, Vol. 312 Issue 5, p477 

    The article the results of several medical research studies. Topics include the link between the use of statins and an increased risk for type 2 diabetes, a molecule that can be used to treat arrhythmogenic cardiomyopathy in zebrafish, and the role of HIV integration sites in the expansion and...

  • Analysis fuels debate on statins for low risk people. Kmietowicz, Zosia // BMJ: British Medical Journal;3/29/2014, Vol. 348 Issue 7951, p1 

    The article discusses how new findings that the risk of harmful effects from statins was very small is fueling a debate on whether statins should be extended to healthy people who are at low risk of cardiovascular disease. It cites the latest analysis of observational studies were researchers...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics